Cash flow Danaher Corporation

Equities

DHR

US2358511028

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2025-06-17 pm EDT			5-day change	1st Jan Change
195.75 ^USD	-2.67%		-1.73%	-14.72%

Jun. 09	Some of the biggest splits in Corporate America	RE
Jun. 09	Some of the biggest splits in Corporate America	RE

86147d581f396b9b1f.0RdTGwJQBe7iL0BZVxx8qiGpjt2PoV69p5elODZOvD4.vF4-UmceWpqSbggsAH893BjHwpfNyh3xwPPCS1Eb7UrlLmZ8dhNjiLd1Iw

Published financial data: DANAHER CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	22.28B	29.45B	31.47B	23.89B	23.88B
Total Revenues	22.28B	29.45B	31.47B	23.89B	23.88B
Cost of Goods Sold, Total	9.35B	11.4B	12.52B	9.76B	9.64B
Gross Profit	12.93B	18.06B	18.95B	14.13B	14.23B
Selling General & Admin Expenses, Total	6.86B	8.15B	8.46B	7.24B	7.49B
R&D Expenses	1.35B	1.74B	1.74B	1.5B	1.58B
Other Operating Expenses, Total	8.21B	9.89B	10.21B	8.75B	9.08B
Operating Income	4.73B	8.17B	8.74B	5.38B	5.15B
Interest Expense, Total	-275M	-238M	-211M	-286M	-278M
Interest And Investment Income	71M	11M	41M	303M	117M
Net Interest Expenses	-204M	-227M	-170M	17M	-161M
Other Non Operating Income (Expenses)	5M	-	-	-	-
EBT, Excl. Unusual Items	4.53B	7.94B	8.57B	5.4B	4.99B
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-457M	-104M	-	-95M	-290M
Gain (Loss) On Sale Of Investments	18M	401M	-271M	-182M	-57M
Gain (Loss) On Sale Of Assets	455M	13M	-	-	-
Asset Writedown	-22M	-10M	-9M	-77M	-
Legal Settlements	-	-547M	-	-	-
Other Unusual Items	-26M	-96M	-	-	-
EBT, Incl. Unusual Items	4.5B	7.6B	8.29B	5.04B	4.65B
Income Tax Expense	849M	1.25B	1.08B	823M	747M
Earnings From Continuing Operations	3.65B	6.35B	7.21B	4.22B	3.9B
Earnings Of Discontinued Operations	-	86M	-	543M	-
Net Income to Company	3.65B	6.43B	7.21B	4.76B	3.9B
Net Income - (IS)	3.65B	6.43B	7.21B	4.76B	3.9B
Preferred Dividend and Other Adjustments	136M	164M	106M	21M	-
Net Income to Common Incl Extra Items	3.51B	6.27B	7.1B	4.74B	3.9B
Net Income to Common Excl. Extra Items	3.51B	6.18B	7.1B	4.2B	3.9B
Per Share Items
Net EPS - Basic	4.97	8.77	9.8	6.44	5.33
Basic EPS - Continuing Operations	4.97	8.65	9.8	5.7	5.33
Basic Weighted Average Shares Outstanding	706M	715M	725M	736M	731M
Net EPS - Diluted	4.89	8.61	9.66	6.38	5.29
Diluted EPS - Continuing Operations	4.89	8.5	9.66	5.65	5.29
Diluted Weighted Average Shares Outstanding	719M	737M	737M	743M	737M
Normalized Basic EPS	4.01	6.95	7.39	4.58	4.27
Normalized Diluted EPS	3.94	6.74	7.27	4.54	4.23
Dividend Per Share	0.72	0.84	1	1.05	1.08
Payout Ratio	16.87	11.53	11.35	17.23	19.7
American Depositary Receipts Ratio (ADR)	0.04	0.04	0.04	0.04	0.04
Supplemental Items
EBITDA	6.5B	10.34B	10.96B	7.55B	7.51B
EBITA	5.86B	9.62B	10.23B	6.87B	6.78B
EBIT	4.73B	8.17B	8.74B	5.38B	5.15B
EBITDAR	6.76B	10.64B	11.28B	7.82B	7.8B
Effective Tax Rate - (Ratio)	18.89	16.46	13.06	16.32	16.08
Current Domestic Taxes	-249M	346M	413M	756M	301M
Current Foreign Taxes	580M	1.13B	1.23B	1.27B	929M
Total Current Taxes	331M	1.48B	1.64B	2.03B	1.23B
Deferred Domestic Taxes	534M	-206M	-400M	-866M	-342M
Deferred Foreign Taxes	-16M	-23M	-159M	-338M	-141M
Total Deferred Taxes	518M	-229M	-559M	-1.2B	-483M
Normalized Net Income	2.83B	4.96B	5.36B	3.37B	3.12B
Non-Cash Pension Expense	-19M	-44M	-47M	-10M	-3M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.35B	1.74B	1.74B	1.5B	1.58B
Net Rental Expense, Total	262M	305M	312M	274M	299M
Imputed Operating Lease Interest Expense	25.79M	25.55M	23.93M	31.23M	36.26M
Imputed Operating Lease Depreciation	236M	279M	288M	243M	263M
Stock-Based Comp., SG&A Exp. (Total)	187M	218M	336M	306M	288M
Total Stock-Based Compensation	187M	218M	336M	306M	288M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	6.04B	2.59B	6B	5.86B	2.08B
Total Cash And Short Term Investments	6.04B	2.59B	6B	5.86B	2.08B
Accounts Receivable, Total	4.11B	4.63B	5.01B	3.98B	3.54B
Other Receivables	700M	-	962M	715M	853M
Total Receivables	4.81B	4.63B	5.97B	4.69B	4.39B
Inventory	2.29B	2.77B	3.11B	2.59B	2.33B
Prepaid Expenses	665M	1.66B	802M	771M	699M
Other Current Assets, Total	-	-	6M	17M	-
Total Current Assets	13.8B	11.65B	15.88B	13.94B	9.5B
Gross Property Plant And Equipment	7.39B	8.3B	8.85B	9.43B	10.18B
Accumulated Depreciation	-3.18B	-3.46B	-3.89B	-3.83B	-4.1B
Net Property Plant And Equipment	4.2B	4.83B	4.96B	5.6B	6.07B
Long-term Investments	27M	20M	11M	5M	-
Goodwill	35.42B	41.18B	39.75B	41.61B	40.5B
Other Intangibles, Total	21.28B	22.84B	20.3B	20.75B	18.57B
Deferred Tax Assets Long-Term	1.34B	1.23B	1.43B	1.9B	2.29B
Other Long-Term Assets, Total	88M	1.42B	2.02B	682M	614M
Total Assets	76.16B	83.18B	84.35B	84.49B	77.54B
Liabilities
Accounts Payable, Total	2.05B	2.57B	2.3B	1.77B	1.75B
Accrued Expenses, Total	1.66B	1.66B	1.63B	1.34B	1.34B
Current Portion of Long-Term Debt	11M	8M	591M	1.7B	505M
Current Portion of Leases	189M	207M	199M	180M	173M
Current Income Taxes Payable	552M	707M	691M	582M	568M
Unearned Revenue Current, Total	1.21B	1.61B	1.65B	1.46B	1.3B
Other Current Liabilities	1.73B	1.37B	1.33B	1.25B	1.16B
Total Current Liabilities	7.4B	8.14B	8.39B	8.27B	6.8B
Long-Term Debt	21.19B	22.17B	19.09B	16.71B	15.5B
Long-Term Leases	785M	889M	863M	954M	968M
Unearned Revenue Non Current	205M	213M	235M	249M	232M
Pension & Other Post Retirement Benefits	1.5B	876M	506M	544M	560M
Other Non Current Liabilities	5.3B	5.72B	5.18B	4.27B	3.93B
Total Liabilities	36.38B	38.01B	34.26B	31B	27.99B
Preferred Stock Convertible	3.27B	3.27B	1.67B	-	-
Total Preferred Equity	3.27B	3.27B	1.67B	-	-
Common Stock, Total	9M	9M	9M	9M	9M
Additional Paid In Capital	9.7B	10.09B	12.07B	14.15B	16.73B
Retained Earnings	27.16B	32.83B	39.2B	41.07B	44.19B
Treasury Stock	-	-	-	-	-8.16B
Comprehensive Income and Other	-368M	-1.03B	-2.87B	-1.75B	-3.22B
Total Common Equity	36.5B	41.9B	48.41B	53.49B	49.54B
Minority Interest	11M	10M	8M	4M	7M
Total Equity	39.78B	45.18B	50.09B	53.49B	49.55B
Total Liabilities And Equity	76.16B	83.18B	84.35B	84.49B	77.54B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	712M	715M	729M	740M	715M
ECS Total Common Shares Outstanding	711M	715M	728M	739M	719M
Book Value / Share	51.33	58.6	66.48	72.36	68.9
Tangible Book Value	-20.2B	-22.13B	-11.64B	-8.87B	-9.52B
Tangible Book Value Per Share	-28.42	-30.95	-15.98	-12	-13.24
Total Debt	22.18B	23.27B	20.74B	19.54B	17.15B
Net Debt	16.14B	20.69B	14.74B	13.67B	15.07B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.42B	813M	459M	503M	313M
Debt Equivalent Oper. Leases	2.1B	2.44B	2.5B	2.19B	2.39B
Minority Interest, Total (Incl. Fin. Div)	11M	10M	8M	4M	7M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	691M	951M	1.13B	853M	720M
Inventories - Work In Process, Total	369M	473M	473M	459M	465M
Inventories - Finished Goods, Total	1.23B	1.34B	1.5B	1.28B	1.14B
Land - (BS)	192M	203M	216M	210M	230M
Buildings, Total	1.52B	1.68B	1.99B	2.27B	2.55B
Machinery, Total	2.88B	3.61B	3.94B	4.11B	4.43B
Full Time Employees	67K	78K	79K	61K	61K
Part Time Employees	2K	2K	2K	2K	2K
Assets on Operating Lease - Gross	1.85B	1.77B	1.7B	1.79B	1.88B
Accumulated Allowance for Doubtful Accounts (Supple)	132M	124M	126M	120M	113M
Order Backlog	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	3.65B	6.43B	7.21B	4.76B	3.9B
Depreciation & Amortization - CF	637M	718M	738M	675M	721M
Amortization of Goodwill and Intangible Assets - (CF)	1.14B	1.45B	1.48B	1.49B	1.63B
Depreciation & Amortization, Total	1.78B	2.17B	2.22B	2.17B	2.35B
(Gain) Loss From Sale Of Asset	-455M	-13M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-401M	271M	182M	57M
Asset Writedown & Restructuring Costs	-	-	-	-	265M
Stock-Based Compensation (CF)	187M	218M	336M	306M	288M
Net Cash From Discontinued Operations	-7M	-	-	674M	-
Other Operating Activities, Total	457M	611M	-	-535M	25M
Change In Accounts Receivable	-264M	-611M	-477M	322M	331M
Change In Inventories	-123M	-502M	-486M	185M	147M
Change In Accounts Payable	227M	549M	5M	-149M	19M
Change In Deferred Taxes	518M	-229M	-559M	-1.2B	-483M
Change in Other Net Operating Assets	247M	135M	-2M	453M	-212M
Cash from Operations	6.21B	8.36B	8.52B	7.16B	6.69B
Capital Expenditure	-791M	-1.29B	-1.15B	-1.38B	-1.39B
Sale of Property, Plant, and Equipment	2M	13M	9M	12M	13M
Cash Acquisitions	-20.97B	-10.96B	-637M	-5.61B	-558M
Divestitures	826M	26M	-	-	-
Investment in Marketable and Equity Securities, Total	-329M	-808M	-505M	-111M	-78M
Other Investing Activities, Total	24M	37M	51M	11M	34M
Cash from Investing	-21.24B	-12.99B	-2.23B	-7.08B	-1.98B
Short Term Debt Issued, Total	-	2.26B	-	-	5M
Long-Term Debt Issued, Total	8.67B	984M	-	-	-
Total Debt Issued	8.67B	3.25B	-	-	5M
Short Term Debt Repaid, Total	-4.64B	-	-723M	-1.01B	-
Long-Term Debt Repaid, Total	-5.93B	-1.19B	-965M	-620M	-1.67B
Total Debt Repaid	-10.57B	-1.19B	-1.69B	-1.63B	-1.67B
Issuance of Common Stock	1.88B	86M	31M	68M	162M
Repurchase of Common Stock	-	-	-	-	-5.98B
Issuance of Preferred Stock	1.67B	-	-	-	-
Common Dividends Paid	-500M	-578M	-693M	-778M	-768M
Preferred Dividends Paid	-115M	-164M	-125M	-43M	-
Common & Preferred Stock Dividends Paid	-615M	-742M	-818M	-821M	-768M
Other Financing Activities, Total	-29M	-112M	-95M	2.11B	-131M
Cash from Financing	1.01B	1.3B	-2.57B	-273M	-8.38B
Foreign Exchange Rate Adjustments	148M	-115M	-306M	59M	-108M
Net Change in Cash	-13.88B	-3.45B	3.41B	-131M	-3.79B
Supplemental Items
Cash Interest Paid	331M	452M	347M	392M	370M
Cash Income Tax Paid (Refund)	1.1B	1.7B	1.8B	1.8B	1.3B
Levered Free Cash Flow	4.51B	5.48B	5.59B	4.86B	4.67B
Unlevered Free Cash Flow	4.68B	5.62B	5.72B	5.04B	4.84B
Change In Net Working Capital	-557M	572M	1.15B	-583M	-375M
Net Debt Issued / Repaid	-1.9B	2.06B	-1.69B	-1.63B	-1.67B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.27	6.41	6.52	3.98	3.98
Return on Total Capital	5.15	7.83	7.85	4.68	4.61
Return On Equity %	10.41	14.94	15.13	8.15	7.57
Return on Common Equity	10.77	15.77	15.73	8.24	7.57
Margin Analysis
Gross Profit Margin %	58.03	61.3	60.21	59.14	59.61
SG&A Margin	30.78	27.66	26.89	30.33	31.38
EBITDA Margin %	29.17	35.09	34.84	31.59	31.44
EBITA Margin %	26.31	32.66	32.49	28.77	28.42
EBIT Margin %	21.21	27.73	27.78	22.52	21.59
Income From Continuing Operations Margin %	16.36	21.55	22.91	17.67	16.33
Net Income Margin %	16.36	21.84	22.91	19.94	16.33
Net Avail. For Common Margin %	15.75	20.99	22.57	17.58	16.33
Normalized Net Income Margin	12.7	16.85	17.02	14.12	13.07
Levered Free Cash Flow Margin	20.24	18.59	17.75	20.33	19.56
Unlevered Free Cash Flow Margin	21.01	19.1	18.17	21.08	20.29
Asset Turnover
Asset Turnover	0.32	0.37	0.38	0.28	0.29
Fixed Assets Turnover	6.13	6.52	6.43	4.69	4.09
Receivables Turnover (Average Receivables)	6.04	6.74	6.48	5.86	6.4
Inventory Turnover (Average Inventory)	4.77	4.51	4.26	3.64	3.92
Short Term Liquidity
Current Ratio	1.86	1.43	1.89	1.68	1.4
Quick Ratio	1.47	0.89	1.43	1.28	0.95
Operating Cash Flow to Current Liabilities	0.84	1.03	1.02	0.87	0.98
Days Sales Outstanding (Average Receivables)	60.59	54.16	56.33	62.3	57.17
Days Outstanding Inventory (Average Inventory)	76.71	81.01	85.65	100.2	93.44
Average Days Payable Outstanding	65.12	70.99	69.01	68.93	68.65
Cash Conversion Cycle (Average Days)	72.18	64.18	72.97	93.57	81.95
Long Term Solvency
Total Debt/Equity	55.76	51.51	41.4	36.52	34.6
Total Debt / Total Capital	35.8	34	29.28	26.75	25.71
LT Debt/Equity	55.25	51.04	39.83	33.02	33.24
Long-Term Debt / Total Capital	35.47	33.68	28.16	24.18	24.69
Total Liabilities / Total Assets	47.77	45.69	40.62	36.69	36.1
EBIT / Interest Expense	17.19	34.32	41.43	18.81	18.54
EBITDA / Interest Expense	24.59	44.71	53.44	27.35	28.08
(EBITDA - Capex) / Interest Expense	21.72	39.27	47.98	22.51	23.07
Total Debt / EBITDA	3.28	2.19	1.84	2.5	2.2
Net Debt / EBITDA	2.39	1.94	1.31	1.75	1.93
Total Debt / (EBITDA - Capex)	3.71	2.49	2.05	3.03	2.67
Net Debt / (EBITDA - Capex)	2.7	2.21	1.46	2.12	2.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	24.42	32.17	6.85	-10.33	-0.06
Gross Profit, 1 Yr. Growth %	29.53	38.43	4.95	-12.72	0.72
EBITDA, 1 Yr. Growth %	45.44	56.32	6.08	-22.29	-0.54
EBITA, 1 Yr. Growth %	50.13	60.97	6.32	-23.76	-1.27
EBIT, 1 Yr. Growth %	44.04	68.86	7.03	-29.01	-4.22
Earnings From Cont. Operations, 1 Yr. Growth %	49.92	74.08	13.58	-33.3	-7.63
Net Income, 1 Yr. Growth %	21.21	76.44	12.06	-33.92	-18.16
Normalized Net Income, 1 Yr. Growth %	36.68	71.22	7.95	-27.22	-7.5
Diluted EPS Before Extra, 1 Yr. Growth %	49.8	73.94	13.72	-33.28	-6.37
Accounts Receivable, 1 Yr. Growth %	25.76	12.68	6.42	-4.86	-9.82
Inventory, 1 Yr. Growth %	40.79	20.72	12.4	-6.18	-10.18
Net Property, Plant and Equip., 1 Yr. Growth %	37.12	14.91	2.61	22.03	8.37
Total Assets, 1 Yr. Growth %	22.68	9.22	1.4	0.16	-8.22
Tangible Book Value, 1 Yr. Growth %	432.81	9.52	-47.41	2.13	7.37
Common Equity, 1 Yr. Growth %	27.3	14.8	15.55	10.48	-7.37
Cash From Operations, 1 Yr. Growth %	57.08	34.63	1.93	-15.91	-6.64
Capital Expenditures, 1 Yr. Growth %	24.37	63.59	-10.97	23.7	0.65
Levered Free Cash Flow, 1 Yr. Growth %	45.98	19.59	2	1.2	-3.83
Unlevered Free Cash Flow, 1 Yr. Growth %	48.3	18.39	1.65	2.2	-3.79
Dividend Per Share, 1 Yr. Growth %	5.88	16.67	19.05	5	2.86
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	14.33	28.23	18.84	-1.86	-5.34
Gross Profit, 2 Yr. CAGR %	16.64	34.48	20.53	-4.04	-6.24
EBITDA, 2 Yr. CAGR %	23.42	52.06	28.99	-9.15	-12.09
EBITA, 2 Yr. CAGR %	25.79	56.92	31.06	-9.93	-13.24
EBIT, 2 Yr. CAGR %	23.67	57.78	34.74	-12.83	-17.54
Earnings From Cont. Operations, 2 Yr. CAGR %	23.1	61.55	40.61	-11.97	-21.5
Net Income, 2 Yr. CAGR %	17.27	46.24	40.61	-13.94	-26.46
Normalized Net Income, 2 Yr. CAGR %	23.63	54.84	36.27	-11.31	-17.95
Diluted EPS Before Extra, 2 Yr. CAGR %	20.03	61.42	40.65	-11.88	-20.96
Accounts Receivable, 2 Yr. CAGR %	14.93	19.04	10.39	-8.08	-8
Inventory, 2 Yr. CAGR %	18.53	30.37	16.49	-3.18	-8.2
Net Property, Plant and Equip., 2 Yr. CAGR %	36.7	25.53	8.59	7.71	15
Total Assets, 2 Yr. CAGR %	26.18	15.75	5.24	0.78	-4.12
Tangible Book Value, 2 Yr. CAGR %	108.47	141.57	-24.1	-36.69	4.72
Common Equity, 2 Yr. CAGR %	13.74	20.89	15.17	12.98	1.16
Cash From Operations, 2 Yr. CAGR %	24.24	45.43	17.14	-7.42	-11.4
Capital Expenditures, 2 Yr. CAGR %	16.38	42.64	20.68	5.61	11.58
Levered Free Cash Flow, 2 Yr. CAGR %	29.64	33.14	10.61	1.48	-1.35
Unlevered Free Cash Flow, 2 Yr. CAGR %	30.03	33.48	9.86	1.78	-0.84
Dividend Per Share, 2 Yr. CAGR %	6.07	11.14	17.85	11.8	3.92
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.82	19.99	20.67	2.35	-1.26
Gross Profit, 3 Yr. CAGR %	14.69	23.85	23.81	2.7	-2.48
EBITDA, 3 Yr. CAGR %	20.45	34.29	34.86	4.62	-6.37
EBITA, 3 Yr. CAGR %	22.6	37.42	37.82	4.9	-7.13
EBIT, 3 Yr. CAGR %	21.99	38.27	38.63	3.77	-10.05
Earnings From Cont. Operations, 3 Yr. CAGR %	18.84	38.17	43.65	5	-10.55
Net Income, 3 Yr. CAGR %	13.52	34.38	33.82	9.32	-15.37
Normalized Net Income, 3 Yr. CAGR %	22.37	38.92	37.3	5.36	-10.06
Diluted EPS Before Extra, 3 Yr. CAGR %	16.63	35.83	43.63	4.97	-10.08
Accounts Receivable, 3 Yr. CAGR %	5.28	14.17	15.29	-1.1	-9.08
Inventory, 3 Yr. CAGR %	7.58	19.26	24.08	4.21	-5.57
Net Property, Plant and Equip., 3 Yr. CAGR %	19.64	29.02	17.37	10.06	7.93
Total Assets, 3 Yr. CAGR %	17.75	20.26	10.76	3.52	-2.31
Tangible Book Value, 3 Yr. CAGR %	24.59	68.21	45.32	-24	-24.5
Common Equity, 3 Yr. CAGR %	11.46	14.09	19.08	13.59	5.74
Cash From Operations, 3 Yr. CAGR %	21.31	27.61	29.18	4.89	-7.16
Capital Expenditures, 3 Yr. CAGR %	11.5	30.37	21.9	20.47	3.93
Levered Free Cash Flow, 3 Yr. CAGR %	30.86	26.84	21.83	2.08	-0.32
Unlevered Free Cash Flow, 3 Yr. CAGR %	30.63	26.65	21.9	2.05	-0.11
Dividend Per Share, 3 Yr. CAGR %	8.74	9.49	13.72	13.4	8.74
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.07	11.77	15.19	6.98	5.92
Gross Profit, 5 Yr. CAGR %	10.58	14.04	17.19	8.25	7.35
EBITDA, 5 Yr. CAGR %	15.18	20.72	24.13	12.08	10.92
EBITA, 5 Yr. CAGR %	16.58	22.5	26.3	13.14	11.68
EBIT, 5 Yr. CAGR %	15.23	22.98	27.42	11.73	9.45
Earnings From Cont. Operations, 5 Yr. CAGR %	15.86	24.13	27.11	11.9	9.9
Net Income, 5 Yr. CAGR %	1.66	20.3	23.67	12.44	5.33
Normalized Net Income, 5 Yr. CAGR %	15.61	23.91	28.25	12.75	8.56
Diluted EPS Before Extra, 5 Yr. CAGR %	14.63	22.51	25.7	10.75	10.16
Accounts Receivable, 5 Yr. CAGR %	6.6	7.77	7.3	5.02	1.59
Inventory, 5 Yr. CAGR %	7.82	10.11	11.06	9.72	7.43
Net Property, Plant and Equip., 5 Yr. CAGR %	12.79	15.46	15.09	20.03	14.65
Total Assets, 5 Yr. CAGR %	9.57	12.93	12.58	12.05	4.55
Tangible Book Value, 5 Yr. CAGR %	20.75	11.85	2.18	13.79	20.22
Common Equity, 5 Yr. CAGR %	9.03	12.74	12.93	13.65	11.56
Cash From Operations, 5 Yr. CAGR %	10.3	18.87	19.62	12.24	11.1
Capital Expenditures, 5 Yr. CAGR %	9.05	17.02	15.08	18.82	16.96
Levered Free Cash Flow, 5 Yr. CAGR %	29.91	15.48	22.65	12.6	8.62
Unlevered Free Cash Flow, 5 Yr. CAGR %	29.08	15.12	22.18	12.7	8.94
Dividend Per Share, 5 Yr. CAGR %	5.92	8.06	12.3	10.41	9.69